Muscular exercise can cause highly pathological liver function tests in healthy men

What is already known about this subject • The occurrence of idiosyncratic drug hepatotoxicity is a major problem in all phases of clinical drug development and the leading cause of postmarketing warnings and withdrawals. • Physical exercise can result in transient elevations of liver function tests...

Full description

Saved in:
Bibliographic Details
Published inBritish journal of clinical pharmacology Vol. 65; no. 2; pp. 253 - 259
Main Authors Pettersson, Jonas, Hindorf, Ulf, Persson, Paula, Bengtsson, Thomas, Malmqvist, Ulf, Werkström, Viktoria, Ekelund, Mats
Format Journal Article
LanguageEnglish
Published Oxford, UK Blackwell Publishing Ltd 01.02.2008
Blackwell Science Inc
Subjects
Online AccessGet full text

Cover

Loading…
Abstract What is already known about this subject • The occurrence of idiosyncratic drug hepatotoxicity is a major problem in all phases of clinical drug development and the leading cause of postmarketing warnings and withdrawals. • Physical exercise can result in transient elevations of liver function tests. • There is no consensus in the literature on which forms of exercise may cause changes in liver function tests and to what extent. What this study adds • Weightlifting results in profound increases in liver function tests in healthy men used to moderate physical activity, not including weightlifting. • Liver function tests are significantly increased for at least 7 days after weightlifting. • It is important to impose relevant restrictions on heavy muscular exercise prior to and during clinical studies. Aim To investigate the effect of intensive muscular exercise (weightlifting) on clinical chemistry parameters reflecting liver function in healthy men. Methods Fifteen healthy men, used to moderate physical activity not including weightlifting, performed an 1 h long weightlifting programme. Blood was sampled for clinical chemistry parameters [aspartate aminotransferase (AST), alanine aminotransferase (ALT), lactate dehydrogenase (LD), gamma‐glutamyl transferase (γGT), alkaline phosphatase (ALP), bilirubin, creatine kinase (CK) and myoglobin] at repeated intervals during 7 days postexercise and at a follow‐up examination 10–12 days postexercise. Results Five out of eight studied clinical chemistry parameters (AST, ALT, LD, CK and myoglobin) increased significantly after exercise (P < 0.01) and remained increased for at least 7 days postexercise. Bilirubin, γGT and ALP remained within the normal range. Conclusion The liver function parameters, AST and ALT, were significantly increased for at least 7 days after the exercise. In addition, LD and, in particular, CK and myoglobin showed highly elevated levels. These findings highlight the importance of imposing restrictions on weightlifting prior to and during clinical studies. Intensive muscular exercise, e.g. weightlifting, should also be considered as a cause of asymptomatic elevations of liver function tests in daily clinical practice.
AbstractList What is already known about this subject • The occurrence of idiosyncratic drug hepatotoxicity is a major problem in all phases of clinical drug development and the leading cause of postmarketing warnings and withdrawals. • Physical exercise can result in transient elevations of liver function tests. • There is no consensus in the literature on which forms of exercise may cause changes in liver function tests and to what extent. What this study adds • Weightlifting results in profound increases in liver function tests in healthy men used to moderate physical activity, not including weightlifting. • Liver function tests are significantly increased for at least 7 days after weightlifting. • It is important to impose relevant restrictions on heavy muscular exercise prior to and during clinical studies. Aim To investigate the effect of intensive muscular exercise (weightlifting) on clinical chemistry parameters reflecting liver function in healthy men. Methods Fifteen healthy men, used to moderate physical activity not including weightlifting, performed an 1 h long weightlifting programme. Blood was sampled for clinical chemistry parameters [aspartate aminotransferase (AST), alanine aminotransferase (ALT), lactate dehydrogenase (LD), gamma-glutamyl transferase (γGT), alkaline phosphatase (ALP), bilirubin, creatine kinase (CK) and myoglobin] at repeated intervals during 7 days postexercise and at a follow-up examination 10–12 days postexercise. Results Five out of eight studied clinical chemistry parameters (AST, ALT, LD, CK and myoglobin) increased significantly after exercise (P < 0.01) and remained increased for at least 7 days postexercise. Bilirubin, γGT and ALP remained within the normal range. Conclusion The liver function parameters, AST and ALT, were significantly increased for at least 7 days after the exercise. In addition, LD and, in particular, CK and myoglobin showed highly elevated levels. These findings highlight the importance of imposing restrictions on weightlifting prior to and during clinical studies. Intensive muscular exercise, e.g. weightlifting, should also be considered as a cause of asymptomatic elevations of liver function tests in daily clinical practice.
The occurrence of idiosyncratic drug hepatotoxicity is a major problem in all phases of clinical drug development and the leading cause of postmarketing warnings and withdrawals. Physical exercise can result in transient elevations of liver function tests. There is no consensus in the literature on which forms of exercise may cause changes in liver function tests and to what extent.WHAT IS ALREADY KNOWN ABOUT THIS SUBJECTThe occurrence of idiosyncratic drug hepatotoxicity is a major problem in all phases of clinical drug development and the leading cause of postmarketing warnings and withdrawals. Physical exercise can result in transient elevations of liver function tests. There is no consensus in the literature on which forms of exercise may cause changes in liver function tests and to what extent.Weightlifting results in profound increases in liver function tests in healthy men used to moderate physical activity, not including weightlifting. Liver function tests are significantly increased for at least 7 days after weightlifting. It is important to impose relevant restrictions on heavy muscular exercise prior to and during clinical studies.WHAT THIS STUDY ADDSWeightlifting results in profound increases in liver function tests in healthy men used to moderate physical activity, not including weightlifting. Liver function tests are significantly increased for at least 7 days after weightlifting. It is important to impose relevant restrictions on heavy muscular exercise prior to and during clinical studies.To investigate the effect of intensive muscular exercise (weightlifting) on clinical chemistry parameters reflecting liver function in healthy men.AIMTo investigate the effect of intensive muscular exercise (weightlifting) on clinical chemistry parameters reflecting liver function in healthy men.Fifteen healthy men, used to moderate physical activity not including weightlifting, performed an 1 h long weightlifting programme. Blood was sampled for clinical chemistry parameters [aspartate aminotransferase (AST), alanine aminotransferase (ALT), lactate dehydrogenase (LD), gamma-glutamyl transferase (gamma GT), alkaline phosphatase (ALP), bilirubin, creatine kinase (CK) and myoglobin] at repeated intervals during 7 days postexercise and at a follow-up examination 10-12 days postexercise.METHODSFifteen healthy men, used to moderate physical activity not including weightlifting, performed an 1 h long weightlifting programme. Blood was sampled for clinical chemistry parameters [aspartate aminotransferase (AST), alanine aminotransferase (ALT), lactate dehydrogenase (LD), gamma-glutamyl transferase (gamma GT), alkaline phosphatase (ALP), bilirubin, creatine kinase (CK) and myoglobin] at repeated intervals during 7 days postexercise and at a follow-up examination 10-12 days postexercise.Five out of eight studied clinical chemistry parameters (AST, ALT, LD, CK and myoglobin) increased significantly after exercise (P < 0.01) and remained increased for at least 7 days postexercise. Bilirubin, gamma GT and ALP remained within the normal range.RESULTSFive out of eight studied clinical chemistry parameters (AST, ALT, LD, CK and myoglobin) increased significantly after exercise (P < 0.01) and remained increased for at least 7 days postexercise. Bilirubin, gamma GT and ALP remained within the normal range.The liver function parameters, AST and ALT, were significantly increased for at least 7 days after the exercise. In addition, LD and, in particular, CK and myoglobin showed highly elevated levels. These findings highlight the importance of imposing restrictions on weightlifting prior to and during clinical studies. Intensive muscular exercise, e.g. weightlifting, should also be considered as a cause of asymptomatic elevations of liver function tests in daily clinical practice.CONCLUSIONThe liver function parameters, AST and ALT, were significantly increased for at least 7 days after the exercise. In addition, LD and, in particular, CK and myoglobin showed highly elevated levels. These findings highlight the importance of imposing restrictions on weightlifting prior to and during clinical studies. Intensive muscular exercise, e.g. weightlifting, should also be considered as a cause of asymptomatic elevations of liver function tests in daily clinical practice.
The occurrence of idiosyncratic drug hepatotoxicity is a major problem in all phases of clinical drug development and the leading cause of postmarketing warnings and withdrawals. Physical exercise can result in transient elevations of liver function tests. There is no consensus in the literature on which forms of exercise may cause changes in liver function tests and to what extent. Weightlifting results in profound increases in liver function tests in healthy men used to moderate physical activity, not including weightlifting. Liver function tests are significantly increased for at least 7 days after weightlifting. It is important to impose relevant restrictions on heavy muscular exercise prior to and during clinical studies. To investigate the effect of intensive muscular exercise (weightlifting) on clinical chemistry parameters reflecting liver function in healthy men. Fifteen healthy men, used to moderate physical activity not including weightlifting, performed an 1 h long weightlifting programme. Blood was sampled for clinical chemistry parameters [aspartate aminotransferase (AST), alanine aminotransferase (ALT), lactate dehydrogenase (LD), gamma-glutamyl transferase (gamma GT), alkaline phosphatase (ALP), bilirubin, creatine kinase (CK) and myoglobin] at repeated intervals during 7 days postexercise and at a follow-up examination 10-12 days postexercise. Five out of eight studied clinical chemistry parameters (AST, ALT, LD, CK and myoglobin) increased significantly after exercise (P < 0.01) and remained increased for at least 7 days postexercise. Bilirubin, gamma GT and ALP remained within the normal range. The liver function parameters, AST and ALT, were significantly increased for at least 7 days after the exercise. In addition, LD and, in particular, CK and myoglobin showed highly elevated levels. These findings highlight the importance of imposing restrictions on weightlifting prior to and during clinical studies. Intensive muscular exercise, e.g. weightlifting, should also be considered as a cause of asymptomatic elevations of liver function tests in daily clinical practice.
What is already known about this subject • The occurrence of idiosyncratic drug hepatotoxicity is a major problem in all phases of clinical drug development and the leading cause of postmarketing warnings and withdrawals. • Physical exercise can result in transient elevations of liver function tests. • There is no consensus in the literature on which forms of exercise may cause changes in liver function tests and to what extent. What this study adds • Weightlifting results in profound increases in liver function tests in healthy men used to moderate physical activity, not including weightlifting. • Liver function tests are significantly increased for at least 7 days after weightlifting. • It is important to impose relevant restrictions on heavy muscular exercise prior to and during clinical studies. Aim To investigate the effect of intensive muscular exercise (weightlifting) on clinical chemistry parameters reflecting liver function in healthy men. Methods Fifteen healthy men, used to moderate physical activity not including weightlifting, performed an 1 h long weightlifting programme. Blood was sampled for clinical chemistry parameters [aspartate aminotransferase (AST), alanine aminotransferase (ALT), lactate dehydrogenase (LD), gamma‐glutamyl transferase (γGT), alkaline phosphatase (ALP), bilirubin, creatine kinase (CK) and myoglobin] at repeated intervals during 7 days postexercise and at a follow‐up examination 10–12 days postexercise. Results Five out of eight studied clinical chemistry parameters (AST, ALT, LD, CK and myoglobin) increased significantly after exercise (P < 0.01) and remained increased for at least 7 days postexercise. Bilirubin, γGT and ALP remained within the normal range. Conclusion The liver function parameters, AST and ALT, were significantly increased for at least 7 days after the exercise. In addition, LD and, in particular, CK and myoglobin showed highly elevated levels. These findings highlight the importance of imposing restrictions on weightlifting prior to and during clinical studies. Intensive muscular exercise, e.g. weightlifting, should also be considered as a cause of asymptomatic elevations of liver function tests in daily clinical practice.
Author Pettersson, Jonas
Malmqvist, Ulf
Werkström, Viktoria
Bengtsson, Thomas
Hindorf, Ulf
Persson, Paula
Ekelund, Mats
Author_xml – sequence: 1
  givenname: Jonas
  surname: Pettersson
  fullname: Pettersson, Jonas
– sequence: 2
  givenname: Ulf
  surname: Hindorf
  fullname: Hindorf, Ulf
– sequence: 3
  givenname: Paula
  surname: Persson
  fullname: Persson, Paula
– sequence: 4
  givenname: Thomas
  surname: Bengtsson
  fullname: Bengtsson, Thomas
– sequence: 5
  givenname: Ulf
  surname: Malmqvist
  fullname: Malmqvist, Ulf
– sequence: 6
  givenname: Viktoria
  surname: Werkström
  fullname: Werkström, Viktoria
– sequence: 7
  givenname: Mats
  surname: Ekelund
  fullname: Ekelund, Mats
BackLink https://www.ncbi.nlm.nih.gov/pubmed/17764474$$D View this record in MEDLINE/PubMed
https://lup.lub.lu.se/record/608027$$DView record from Swedish Publication Index
oai:portal.research.lu.se:publications/cd35c777-2589-48d4-999e-b2c9bcabbf04$$DView record from Swedish Publication Index
BookMark eNqNUk2P0zAUtNAi9gP-AsqJW4vt2HFyAAkqvqQikIDzk-28NK7cpNjJbvvvcbalyx6Qasnykz2eGT_PNbno-g4JyRidszRer-csL-SMMy7nnFI1pzmlbL57Qq5OBxfkKu0WM8kluyTXMa4TJGeFfEYumVKFEEpckR9fx2hHr0OGOwzWRcys7tIcU9W6Vev32VYPbe_7lbPaZ97dYsiasbOD67tswDjEzHVZi9oP7T7bYPecPG20j_jiuN6QXx8__Fx8ni2_ffqyeLec2aJSbCasLo1pkiXTiKKuLM8ploZaJSte64JjRVmjrRQFr2nOpWoKUavGCFMqLU1-Q_SBN97hdjSwDW6jwx567WDbh0F7CBhRB9uCHyEiJJRPr5icR7B1Lq1SCrgsKxBlLaCqKgTDbWWsTtaoSBrL_2r4cZumOXKfSff2QJe4Nlhb7IaQbD5y_uikcy2s-lvgvGKpP4ng1ZEg9L_H1HzYuGjRe91hP0ZQlCshxaT08l-lk8Tfr0-A8gCwoY8xYPMAoTClDNYwhQmmMMGUMrhPGeweXnG6at1w39Xk2flzCN4cCO6cx_3ZwvB-8X2q8j_gtu78
CitedBy_id crossref_primary_10_1016_j_smallrumres_2018_02_011
crossref_primary_10_1128_AAC_02830_14
crossref_primary_10_30699_jambs_27_121_1
crossref_primary_10_4236_crcm_2018_73016
crossref_primary_10_3390_ph17010132
crossref_primary_10_1123_ijspp_5_1_18
crossref_primary_10_1097_MPG_0b013e31818d7da2
crossref_primary_10_2478_aoas_2021_0008
crossref_primary_10_3389_fendo_2021_655756
crossref_primary_10_1016_j_jevs_2015_08_020
crossref_primary_10_2147_SAR_S495789
crossref_primary_10_1016_j_amjcard_2008_07_052
crossref_primary_10_1016_j_apunsm_2023_100404
crossref_primary_10_29219_fnr_v67_9750
crossref_primary_10_1080_1828051X_2018_1472531
crossref_primary_10_1002_cpt_1276
crossref_primary_10_5812_asjsm_109400
crossref_primary_10_54393_fbt_v3i01_36
crossref_primary_10_1186_s40798_022_00463_6
crossref_primary_10_1097_TP_0000000000004610
crossref_primary_10_1080_10495398_2020_1746322
crossref_primary_10_1371_journal_pone_0273719
crossref_primary_10_1186_s12970_016_0132_0
crossref_primary_10_61186_armaghanj_29_1_35
crossref_primary_10_3389_fmed_2022_823898
crossref_primary_10_3390_jfmk2040035
crossref_primary_10_1016_j_gcb_2008_08_007
crossref_primary_10_29252_jcbr_2_2_5
crossref_primary_10_1016_j_cbi_2022_110075
crossref_primary_10_3390_sports10100160
crossref_primary_10_4236_ojgas_2024_148029
crossref_primary_10_4055_cios20205
crossref_primary_10_1016_j_jevs_2019_07_006
crossref_primary_10_1016_j_celrep_2024_113854
crossref_primary_10_3923_jbs_2018_231_242
crossref_primary_10_1016_S1473_3099_21_00679_4
crossref_primary_10_2478_aoas_2020_0052
crossref_primary_10_1111_bjd_21840
crossref_primary_10_3390_ijms24108509
crossref_primary_10_1093_burnst_tkad007
crossref_primary_10_1093_toxsci_kfw090
crossref_primary_10_1002_hep_29802
crossref_primary_10_1016_j_jacr_2023_08_023
crossref_primary_10_5812_whb_57194
crossref_primary_10_1016_j_jevs_2015_07_009
crossref_primary_10_1080_09540105_2018_1439900
crossref_primary_10_1056_NEJMoa1108046
crossref_primary_10_1016_j_smallrumres_2019_04_003
crossref_primary_10_3399_bjgp24X737013
crossref_primary_10_1212_WNL_0b013e31820c3648
crossref_primary_10_1097_GME_0000000000000647
crossref_primary_10_15602_1983_9480_cmbs_v15n30p9_16
crossref_primary_10_23736_S0022_4707_22_13448_1
crossref_primary_10_1111_jpn_13935
crossref_primary_10_1016_j_heliyon_2023_e20427
crossref_primary_10_3357_AMHP_5862_2022
crossref_primary_10_3389_fphys_2020_01001
crossref_primary_10_1002_ccr3_546
crossref_primary_10_1093_advances_nmy115
crossref_primary_10_1088_1742_6596_1462_1_012007
crossref_primary_10_1007_s00204_021_03150_9
crossref_primary_10_1111_asj_13994
crossref_primary_10_31482_mmsl_2023_010
crossref_primary_10_1080_10495398_2019_1625783
crossref_primary_10_1177_0960327121997975
crossref_primary_10_1007_s00108_008_2231_8
crossref_primary_10_1016_j_gastrohep_2016_03_001
crossref_primary_10_1111_liv_12322
crossref_primary_10_22358_jafs_189182_2024
crossref_primary_10_32900_2312_8402_2024_131_253_261
crossref_primary_10_3390_ani12091107
crossref_primary_10_3390_metabo12121283
crossref_primary_10_1111_bjd_14207
crossref_primary_10_1016_j_jhep_2018_04_024
crossref_primary_10_1371_journal_pone_0180840
crossref_primary_10_3390_diagnostics14182014
crossref_primary_10_1016_j_livsci_2017_10_002
crossref_primary_10_1177_1535370217740853
crossref_primary_10_1016_j_smhs_2024_03_002
crossref_primary_10_54393_pbmj_v5i4_209
crossref_primary_10_3923_biotech_2020_18_22
crossref_primary_10_3748_wjg_v26_i10_1020
crossref_primary_10_1016_j_fct_2023_113890
crossref_primary_10_1016_j_scispo_2022_01_005
crossref_primary_10_3109_15376516_2013_843108
crossref_primary_10_3390_jcm9010081
crossref_primary_10_4103_ijnpnd_ijnpnd_96_23
crossref_primary_10_1016_j_smallrumres_2021_106400
crossref_primary_10_1016_j_smallrumres_2021_106522
crossref_primary_10_3390_app14167284
crossref_primary_10_1515_bhk_2018_0014
crossref_primary_10_1038_s41598_018_33008_7
crossref_primary_10_1111_1751_2980_12684
crossref_primary_10_1371_journal_pone_0239158
crossref_primary_10_1016_j_jep_2016_08_010
crossref_primary_10_1038_s41598_024_78590_1
crossref_primary_10_1055_a_1408_4793
crossref_primary_10_1371_journal_pone_0160305
crossref_primary_10_2334_josnusd_16_0367
crossref_primary_10_31196_huvfd_1281402
crossref_primary_10_3390_genes14101891
crossref_primary_10_1111_sms_14554
crossref_primary_10_3810_psm_2010_10_1815
crossref_primary_10_1039_D4FO04931D
crossref_primary_10_2478_aoas_2024_0053
crossref_primary_10_3390_ani14131878
crossref_primary_10_61186_jspac_38872_2_5_50
crossref_primary_10_1039_C7FO00465F
crossref_primary_10_1515_cclm_2023_0313
crossref_primary_10_1007_s12662_020_00662_x
crossref_primary_10_23736_S0022_4707_21_11812_2
crossref_primary_10_29252_mlj_14_1_44
crossref_primary_10_1139_h2012_008
crossref_primary_10_1016_j_anifeedsci_2017_02_012
crossref_primary_10_1016_j_livsci_2017_08_001
crossref_primary_10_7717_peerj_10228
crossref_primary_10_1007_s12291_024_01286_w
crossref_primary_10_5812_jamm_100409
crossref_primary_10_1016_j_smallrumres_2020_106249
crossref_primary_10_1038_ajg_2016_517
crossref_primary_10_1080_16546628_2017_1330098
crossref_primary_10_1089_omi_2015_0065
crossref_primary_10_3923_jas_2019_241_246
crossref_primary_10_1016_j_tice_2024_102680
crossref_primary_10_1039_D0NR01493A
crossref_primary_10_1016_j_yrtph_2009_11_001
crossref_primary_10_3390_diagnostics15020179
crossref_primary_10_3390_ijerph17124375
crossref_primary_10_1038_s41684_020_0503_7
crossref_primary_10_1016_j_livsci_2020_104228
crossref_primary_10_1024_1661_8157_a003873
crossref_primary_10_1024_1661_8157_a003872
crossref_primary_10_1111_j_1365_2125_2012_04369_x
crossref_primary_10_1590_S1984_82502009000200010
crossref_primary_10_1111_bcp_14736
crossref_primary_10_3389_fvets_2022_989606
crossref_primary_10_1038_s41598_023_41908_6
crossref_primary_10_5812_jcrps_105116
crossref_primary_10_1080_02640414_2014_944559
crossref_primary_10_3390_ijerph18041537
crossref_primary_10_3390_ijerph18073581
crossref_primary_10_3892_ijmm_2012_1106
crossref_primary_10_33459_cbubesbd_1250222
crossref_primary_10_1155_2021_6653266
crossref_primary_10_1007_s10735_024_10277_3
crossref_primary_10_4269_ajtmh_19_0846
crossref_primary_10_1016_S1728_869X_09_60011_3
crossref_primary_10_1097_MOG_0b013e3282f9764b
crossref_primary_10_1128_AAC_01371_19
crossref_primary_10_3389_fendo_2022_1059473
crossref_primary_10_1016_j_nut_2016_01_017
crossref_primary_10_1016_j_anifeedsci_2016_04_012
crossref_primary_10_1590_s1806_92902017000800008
crossref_primary_10_1017_S0007114512005879
crossref_primary_10_3109_07420528_2015_1079215
crossref_primary_10_3390_ani10091621
crossref_primary_10_14712_23362936_2022_25
crossref_primary_10_12659_AJCR_890726
crossref_primary_10_1016_j_smallrumres_2024_107305
crossref_primary_10_1016_S1995_7645_14_60293_5
crossref_primary_10_1007_s11332_020_00723_6
crossref_primary_10_1210_er_2013_1058
crossref_primary_10_1007_s11695_009_9806_x
crossref_primary_10_1111_jcpe_13556
crossref_primary_10_1371_journal_pone_0177174
crossref_primary_10_1111_liv_14774
crossref_primary_10_3390_foods11050631
crossref_primary_10_1248_bpb_b18_00504
crossref_primary_10_1542_peds_2015_2940
crossref_primary_10_1111_liv_13441
crossref_primary_10_1515_jbcpp_2017_0069
crossref_primary_10_1080_01443615_2020_1787966
crossref_primary_10_1002_cam4_4473
crossref_primary_10_1155_2018_6484610
crossref_primary_10_1002_hep4_1932
crossref_primary_10_1111_j_1365_2125_2008_03244_x
crossref_primary_10_5812_jhealthscope_100409
crossref_primary_10_1016_j_fct_2022_113445
crossref_primary_10_15616_BSL_2018_24_4_411
crossref_primary_10_1016_j_anndiagpath_2024_152333
crossref_primary_10_1371_journal_pone_0240562
crossref_primary_10_1007_s42978_024_00305_9
crossref_primary_10_1007_s00431_023_04825_4
crossref_primary_10_1017_S0022029918000043
crossref_primary_10_1007_s11606_014_2766_4
crossref_primary_10_3390_gastroent15040075
crossref_primary_10_3390_ijms22136812
crossref_primary_10_1155_2019_1695874
crossref_primary_10_1097_MD_0000000000003843
crossref_primary_10_3390_ani12111432
crossref_primary_10_5352_JLS_2009_19_6_804
crossref_primary_10_1515_cclm_2018_0656
crossref_primary_10_1155_2013_275431
crossref_primary_10_1080_02701367_2022_2068792
crossref_primary_10_3390_ijms23116049
crossref_primary_10_5005_jp_journals_10018_1184
crossref_primary_10_1093_tas_txad010
crossref_primary_10_1186_1556_276X_9_261
crossref_primary_10_1016_j_foodres_2016_03_001
crossref_primary_10_3892_ijmm_2018_3644
crossref_primary_10_4103_jfmpc_jfmpc_1923_22
crossref_primary_10_1024_0300_9831_a000445
crossref_primary_10_3109_10715762_2014_928410
crossref_primary_10_3357_AMHP_6148_2023
crossref_primary_10_1016_j_fct_2013_02_015
crossref_primary_10_1021_acs_analchem_2c00041
crossref_primary_10_1519_JSC_0000000000001102
crossref_primary_10_1111_asj_13858
crossref_primary_10_14218_JCTH_2020_00005
crossref_primary_10_29252_koomesh_22_2_351
crossref_primary_10_1080_10495398_2019_1622556
crossref_primary_10_2478_v10030_008_0022_6
crossref_primary_10_3390_su12208633
crossref_primary_10_1039_C7FO00189D
crossref_primary_10_7883_yoken_JJID_2024_015
crossref_primary_10_3390_nu16183061
crossref_primary_10_33206_mjss_549949
crossref_primary_10_1016_j_gastre_2016_03_011
crossref_primary_10_1016_j_psym_2015_03_002
crossref_primary_10_3389_fnut_2021_740741
crossref_primary_10_1097_MED_0b013e3283524008
crossref_primary_10_1016_j_scispo_2014_09_002
crossref_primary_10_3390_ijerph16183279
crossref_primary_10_3748_wjg_v30_i42_4576
crossref_primary_10_3390_data9010015
crossref_primary_10_2478_aoas_2020_0086
crossref_primary_10_2478_aoas_2020_0083
crossref_primary_10_1111_jdv_19925
crossref_primary_10_1093_toxsci_kfae143
crossref_primary_10_1007_s11377_009_0340_0
crossref_primary_10_1038_s41467_023_36858_6
crossref_primary_10_15407_nnn_18_03_449
crossref_primary_10_3389_fvets_2022_1048409
crossref_primary_10_1080_10495398_2020_1870485
crossref_primary_10_1016_j_jevs_2016_08_016
crossref_primary_10_3390_foods10112628
Cites_doi 10.1136/bjsm.2002.002873
10.1016/S0002-9378(98)70645-3
10.1007/BF00637392
10.1007/s00134-003-1800-5
10.1016/0009-8981(77)90006-7
10.1093/clinchem/47.5.867
10.1016/0264-410X(92)90417-I
10.1111/j.1399-6576.2005.00577.x
10.1055/s-2007-972660
10.1093/clinchem/19.12.1380
10.1016/S0196-0644(94)70356-6
10.1046/j.1365-2125.2003.01969.x
10.1093/ajcp/79.6.716
10.1038/nrd1750
10.1123/ijsn.3.1.76
10.1249/01.mss.0000210192.49210.fc
10.1038/193942a0
10.1093/ndt/9.6.637
ContentType Journal Article
Copyright 2007 The Authors
2007 The Authors Journal compilation © 2007 Blackwell Publishing Ltd 2008
Copyright_xml – notice: 2007 The Authors
– notice: 2007 The Authors Journal compilation © 2007 Blackwell Publishing Ltd 2008
CorporateAuthor Avdelningen för klinisk kemi och farmakologi
Division of Clinical Chemistry and Pharmacology
Faculty of Medicine
Lunds universitet
Department of Laboratory Medicine
Medicinska fakulteten
Lund University
Institutionen för laboratoriemedicin
CorporateAuthor_xml – name: Faculty of Medicine
– name: Medicinska fakulteten
– name: Division of Clinical Chemistry and Pharmacology
– name: Avdelningen för klinisk kemi och farmakologi
– name: Lund University
– name: Institutionen för laboratoriemedicin
– name: Department of Laboratory Medicine
– name: Lunds universitet
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
ADTPV
AOWAS
D95
DOI 10.1111/j.1365-2125.2007.03001.x
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
SwePub
SwePub Articles
SWEPUB Lunds universitet
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList
MEDLINE - Academic
MEDLINE


Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Pharmacy, Therapeutics, & Pharmacology
EISSN 1365-2125
EndPage 259
ExternalDocumentID oai_portal_research_lu_se_publications_cd35c777_2589_48d4_999e_b2c9bcabbf04
oai_lup_lub_lu_se_cd35c777_2589_48d4_999e_b2c9bcabbf04
PMC2291230
17764474
10_1111_j_1365_2125_2007_03001_x
BCP3001
Genre article
Journal Article
Comparative Study
GroupedDBID ---
.3N
.55
.GA
.GJ
.Y3
05W
0R~
10A
1OC
23N
24P
2WC
31~
33P
36B
3O-
3SF
4.4
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5GY
5HH
5LA
5VS
66C
6J9
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
AAESR
AAEVG
AAHHS
AAHQN
AAIPD
AAMNL
AANLZ
AAONW
AASGY
AAXRX
AAYCA
AAZKR
ABCQN
ABCUV
ABEML
ABOCM
ABPVW
ABQWH
ABXGK
ACAHQ
ACCFJ
ACCZN
ACFBH
ACGFO
ACGFS
ACGOF
ACMXC
ACPOU
ACSCC
ACXBN
ACXQS
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADOZA
ADXAS
ADZMN
ADZOD
AEEZP
AEGXH
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFEBI
AFFPM
AFGKR
AFPWT
AFWVQ
AFZJQ
AHBTC
AIACR
AIAGR
AITYG
AIURR
AIWBW
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
ALVPJ
AMBMR
AMYDB
AOIJS
ATUGU
AZBYB
AZVAB
BAFTC
BAWUL
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BY8
C45
CAG
COF
CS3
D-6
D-7
D-E
D-F
DCZOG
DIK
DPXWK
DR2
DRFUL
DRMAN
DRSTM
DU5
E3Z
EBS
EJD
EMOBN
ESX
EX3
F00
F01
F04
F5P
FIJ
FUBAC
G-S
G.N
GODZA
GX1
H.X
HF~
HGLYW
HYE
HZI
HZ~
IHE
IPNFZ
IX1
J0M
K48
KBYEO
LATKE
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LSO
LUTES
LW6
LYRES
MEWTI
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
O66
O9-
OIG
OK1
OVD
P2P
P2W
P2X
P2Z
P4B
P4D
Q.N
Q11
QB0
R.K
ROL
RPM
RX1
SUPJJ
TEORI
TR2
UB1
V8K
W8V
W99
WBKPD
WHWMO
WIH
WIJ
WIK
WIN
WOHZO
WOW
WQJ
WRC
WVDHM
WXI
WXSBR
X7M
XG1
YFH
YOC
YUY
ZGI
ZXP
ZZTAW
~IA
~WT
AAYXX
AEYWJ
AGHNM
AGYGG
CITATION
AAMMB
AEFGJ
AGXDD
AIDQK
AIDYY
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
ADTPV
AOWAS
D95
ID FETCH-LOGICAL-c6971-4ca8bbf316bf46d9c230e8b0c7592da62e901fac5462d03257f64d7fb4b87a5b3
IEDL.DBID DR2
ISSN 0306-5251
1365-2125
IngestDate Fri Aug 29 03:12:28 EDT 2025
Thu Jul 03 05:24:54 EDT 2025
Thu Aug 21 14:10:28 EDT 2025
Fri Jul 11 05:12:27 EDT 2025
Mon Jul 21 06:03:34 EDT 2025
Tue Jul 01 02:29:24 EDT 2025
Thu Apr 24 23:09:08 EDT 2025
Wed Jan 22 16:22:38 EST 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 2
Language English
License http://onlinelibrary.wiley.com/termsAndConditions#vor
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c6971-4ca8bbf316bf46d9c230e8b0c7592da62e901fac5462d03257f64d7fb4b87a5b3
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/2291230
PMID 17764474
PQID 70274544
PQPubID 23479
PageCount 7
ParticipantIDs swepub_primary_oai_portal_research_lu_se_publications_cd35c777_2589_48d4_999e_b2c9bcabbf04
swepub_primary_oai_lup_lub_lu_se_cd35c777_2589_48d4_999e_b2c9bcabbf04
pubmedcentral_primary_oai_pubmedcentral_nih_gov_2291230
proquest_miscellaneous_70274544
pubmed_primary_17764474
crossref_primary_10_1111_j_1365_2125_2007_03001_x
crossref_citationtrail_10_1111_j_1365_2125_2007_03001_x
wiley_primary_10_1111_j_1365_2125_2007_03001_x_BCP3001
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate February 2008
PublicationDateYYYYMMDD 2008-02-01
PublicationDate_xml – month: 02
  year: 2008
  text: February 2008
PublicationDecade 2000
PublicationPlace Oxford, UK
PublicationPlace_xml – name: Oxford, UK
– name: England
PublicationTitle British journal of clinical pharmacology
PublicationTitleAlternate Br J Clin Pharmacol
PublicationYear 2008
Publisher Blackwell Publishing Ltd
Blackwell Science Inc
Publisher_xml – name: Blackwell Publishing Ltd
– name: Blackwell Science Inc
References 1994; 9
2004; 38
1984; 65
1993; 33
2006; 38
2004; 57
1958; 12
1962; 193
1994; 23
1973; 19
1997; 18
2005; 4
2003; 29
2005; 71
1992; 10
2005; 49
1989; 58
2001; 47
1998; 178
1983; 79
1993; 3
1977; 81
Giboney PT. (e_1_2_6_2_2) 2005; 71
Koutedakis Y (e_1_2_6_10_2) 1993; 33
Loll H (e_1_2_6_4_2) 1958; 12
e_1_2_6_20_2
e_1_2_6_8_2
e_1_2_6_7_2
e_1_2_6_18_2
Statland BE (e_1_2_6_19_2) 1973; 19
e_1_2_6_9_2
Dajani LK (e_1_2_6_21_2) 2001; 47
e_1_2_6_3_2
e_1_2_6_5_2
e_1_2_6_12_2
Hong CZ (e_1_2_6_6_2) 1984; 65
e_1_2_6_13_2
e_1_2_6_23_2
e_1_2_6_22_2
e_1_2_6_11_2
e_1_2_6_16_2
e_1_2_6_17_2
e_1_2_6_14_2
e_1_2_6_15_2
8499940 - Int J Sport Nutr. 1993 Mar;3(1):76-86
11325890 - Clin Chem. 2001 May;47(5):867-73
15931258 - Nat Rev Drug Discov. 2005 Jun;4(6):489-99
13582699 - Arztl Forsch. 1958 Oct 10;12(10):II/85-6
12768237 - Intensive Care Med. 2003 Jul;29(7):1121-5
8107477 - J Sports Med Phys Fitness. 1993 Sep;33(3):252-7
15954972 - Acta Anaesthesiol Scand. 2005 Jul;49(6):859-64
6742992 - Arch Phys Med Rehabil. 1984 Jul;65(7):362-5
16679975 - Med Sci Sports Exerc. 2006 Apr;38(4):623-7
15155430 - Br J Sports Med. 2004 Jun;38(3):292-4
13903983 - Nature. 1962 Mar 10;193:942-4
14748819 - Br J Clin Pharmacol. 2004 Feb;57(2):199-208
9465822 - Am J Obstet Gynecol. 1998 Jan;178(1 Pt 1):161-5
589794 - Clin Chim Acta. 1977 Dec 1;81(2):145-52
15791889 - Am Fam Physician. 2005 Mar 15;71(6):1105-10
6846261 - Am J Clin Pathol. 1983 Jun;79(6):716-9
1539458 - Vaccine. 1992;10(1):39-42
9351689 - Int J Sports Med. 1997 Aug;18(6):431-7
7970089 - Nephrol Dial Transplant. 1994;9(6):637-41
18662292 - Br J Clin Pharmacol. 2008 Nov;66(5):725
4757367 - Clin Chem. 1973 Dec;19(12):1380-3
2737198 - Eur J Appl Physiol Occup Physiol. 1989;58(7):786-90
8198305 - Ann Emerg Med. 1994 Jun;23(6):1301-6
References_xml – volume: 38
  start-page: 623
  year: 2006
  end-page: 7
  article-title: Serum creatine kinase and renal function measures in exertional muscle damage
  publication-title: Med Sci Sports Exerc
– volume: 23
  start-page: 1301
  year: 1994
  end-page: 6
  article-title: Exercise‐induced rhabdomyolysis
  publication-title: Ann Emerg Med
– volume: 38
  start-page: 292
  year: 2004
  end-page: 4
  article-title: Effects of prolonged strenuous exercise (marathon running) on biochemical and haematological markers used in the investigation of patients in the emergency department
  publication-title: Br J Sports Med
– volume: 57
  start-page: 199
  year: 2004
  end-page: 208
  article-title: The influence of diet upon liver function tests and serum lipids in healthy male volunteers resident in a Phase I unit
  publication-title: Br J Clin Pharmacol
– volume: 18
  start-page: 431
  year: 1997
  end-page: 7
  article-title: The effect of training status on the serum creatine kinase response, soreness and muscle function following resistance exercise
  publication-title: Int J Sports Med
– volume: 58
  start-page: 786
  year: 1989
  end-page: 90
  article-title: Serum and urinary markers of skeletal muscle tissue damage after weight lifting exercise
  publication-title: Eur J Appl Physiol Occup Physiol
– volume: 19
  start-page: 1380
  year: 1973
  end-page: 3
  article-title: Factors contributing to intra‐individual variation of serum constituents: 2. Effects of exercise and diet on variation of serum constituents in healthy subjects
  publication-title: Clin Chem
– volume: 4
  start-page: 489
  year: 2005
  end-page: 99
  article-title: Idiosyncratic drug hepatotoxicity
  publication-title: Nat Rev Drug Dis
– volume: 29
  start-page: 1121
  year: 2003
  end-page: 5
  article-title: Serum creatine kinase as a predictor of clinical course in rhabdomyolysis: a 5‐year intensive care survey
  publication-title: Intens Care Med
– volume: 33
  start-page: 252
  year: 1993
  end-page: 7
  article-title: Serum enzyme activities in individuals with different levels of physical fitness
  publication-title: J Sports Med Phys Fitness
– volume: 71
  start-page: 1105
  year: 2005
  end-page: 10
  article-title: Mildly elevated liver transaminase levels in the asymptomatic patient
  publication-title: Am Fam Physician
– volume: 81
  start-page: 145
  year: 1977
  end-page: 52
  article-title: The effects of near maximum exercise on serum enzymes: the exercise profile versus the cardiac profile
  publication-title: Clin Chim Acta
– volume: 79
  start-page: 716
  year: 1983
  end-page: 9
  article-title: Serum enzyme changes during marathon training
  publication-title: Am J Clin Pathol
– volume: 178
  start-page: 161
  year: 1998
  end-page: 5
  article-title: Plasma gluthatione S‐transferase alpha 1‐1: a more sensitive marker for hepatocellular damage than serum alanine aminotransferase in hypertensive disorders of pregnancy
  publication-title: Am J Obstet Gynecol
– volume: 12
  start-page: II/85
  year: 1958
  end-page: 6
  article-title: ]
  publication-title: Artzl Forsch
– volume: 3
  start-page: 76
  year: 1993
  end-page: 86
  article-title: Diet and exercise strategies of a world‐class bodybuilder
  publication-title: Int J Sport Nutr
– volume: 49
  start-page: 859
  year: 2005
  end-page: 64
  article-title: Prognostic value, kinetics and effect of CVVHDF on serum of the myoglobin and creatine kinase in critically ill patients with rhabdomyolysis
  publication-title: Acta Anaesthesiol Scand
– volume: 193
  start-page: 942
  year: 1962
  end-page: 4
  article-title: Effect of physical exercise on some enzymes in the serum
  publication-title: Nature
– volume: 65
  start-page: 362
  year: 1984
  end-page: 5
  article-title: Metabolic effects of exhaustive training of athletes
  publication-title: Arch Phys Med Rehabil
– volume: 10
  start-page: 39
  year: 1992
  end-page: 42
  article-title: Strenuous exercise simulating hepatic injury during vaccine trials
  publication-title: Vaccine
– volume: 9
  start-page: 637
  year: 1994
  end-page: 41
  article-title: Relationship between elevated creatine phosphokinase and the clinical spectrum of rhabdomyolysis
  publication-title: Nephrol Dial Transplant
– volume: 47
  start-page: 867
  year: 2001
  end-page: 73
  article-title: Development of a rapid and sensitive immunofluorometric assay for gluthatione S‐transferase A
  publication-title: Clin Chem
– ident: e_1_2_6_14_2
  doi: 10.1136/bjsm.2002.002873
– ident: e_1_2_6_22_2
  doi: 10.1016/S0002-9378(98)70645-3
– ident: e_1_2_6_13_2
  doi: 10.1007/BF00637392
– ident: e_1_2_6_16_2
  doi: 10.1007/s00134-003-1800-5
– ident: e_1_2_6_23_2
  doi: 10.1016/0009-8981(77)90006-7
– volume: 33
  start-page: 252
  year: 1993
  ident: e_1_2_6_10_2
  article-title: Serum enzyme activities in individuals with different levels of physical fitness
  publication-title: J Sports Med Phys Fitness
– volume: 47
  start-page: 867
  year: 2001
  ident: e_1_2_6_21_2
  article-title: Development of a rapid and sensitive immunofluorometric assay for gluthatione S‐transferase A
  publication-title: Clin Chem
  doi: 10.1093/clinchem/47.5.867
– volume: 71
  start-page: 1105
  year: 2005
  ident: e_1_2_6_2_2
  article-title: Mildly elevated liver transaminase levels in the asymptomatic patient
  publication-title: Am Fam Physician
– ident: e_1_2_6_12_2
  doi: 10.1016/0264-410X(92)90417-I
– ident: e_1_2_6_20_2
  doi: 10.1111/j.1399-6576.2005.00577.x
– ident: e_1_2_6_9_2
  doi: 10.1055/s-2007-972660
– volume: 12
  start-page: II/85
  year: 1958
  ident: e_1_2_6_4_2
  article-title: ]
  publication-title: Artzl Forsch
– volume: 19
  start-page: 1380
  year: 1973
  ident: e_1_2_6_19_2
  article-title: Factors contributing to intra‐individual variation of serum constituents: 2. Effects of exercise and diet on variation of serum constituents in healthy subjects
  publication-title: Clin Chem
  doi: 10.1093/clinchem/19.12.1380
– ident: e_1_2_6_18_2
  doi: 10.1016/S0196-0644(94)70356-6
– ident: e_1_2_6_3_2
  doi: 10.1046/j.1365-2125.2003.01969.x
– ident: e_1_2_6_7_2
  doi: 10.1093/ajcp/79.6.716
– ident: e_1_2_6_11_2
  doi: 10.1038/nrd1750
– volume: 65
  start-page: 362
  year: 1984
  ident: e_1_2_6_6_2
  article-title: Metabolic effects of exhaustive training of athletes
  publication-title: Arch Phys Med Rehabil
– ident: e_1_2_6_8_2
  doi: 10.1123/ijsn.3.1.76
– ident: e_1_2_6_15_2
  doi: 10.1249/01.mss.0000210192.49210.fc
– ident: e_1_2_6_5_2
  doi: 10.1038/193942a0
– ident: e_1_2_6_17_2
  doi: 10.1093/ndt/9.6.637
– reference: 7970089 - Nephrol Dial Transplant. 1994;9(6):637-41
– reference: 6846261 - Am J Clin Pathol. 1983 Jun;79(6):716-9
– reference: 8499940 - Int J Sport Nutr. 1993 Mar;3(1):76-86
– reference: 6742992 - Arch Phys Med Rehabil. 1984 Jul;65(7):362-5
– reference: 2737198 - Eur J Appl Physiol Occup Physiol. 1989;58(7):786-90
– reference: 9351689 - Int J Sports Med. 1997 Aug;18(6):431-7
– reference: 11325890 - Clin Chem. 2001 May;47(5):867-73
– reference: 14748819 - Br J Clin Pharmacol. 2004 Feb;57(2):199-208
– reference: 9465822 - Am J Obstet Gynecol. 1998 Jan;178(1 Pt 1):161-5
– reference: 8107477 - J Sports Med Phys Fitness. 1993 Sep;33(3):252-7
– reference: 8198305 - Ann Emerg Med. 1994 Jun;23(6):1301-6
– reference: 18662292 - Br J Clin Pharmacol. 2008 Nov;66(5):725
– reference: 15791889 - Am Fam Physician. 2005 Mar 15;71(6):1105-10
– reference: 15155430 - Br J Sports Med. 2004 Jun;38(3):292-4
– reference: 16679975 - Med Sci Sports Exerc. 2006 Apr;38(4):623-7
– reference: 15931258 - Nat Rev Drug Discov. 2005 Jun;4(6):489-99
– reference: 13582699 - Arztl Forsch. 1958 Oct 10;12(10):II/85-6
– reference: 13903983 - Nature. 1962 Mar 10;193:942-4
– reference: 1539458 - Vaccine. 1992;10(1):39-42
– reference: 12768237 - Intensive Care Med. 2003 Jul;29(7):1121-5
– reference: 589794 - Clin Chim Acta. 1977 Dec 1;81(2):145-52
– reference: 15954972 - Acta Anaesthesiol Scand. 2005 Jul;49(6):859-64
– reference: 4757367 - Clin Chem. 1973 Dec;19(12):1380-3
SSID ssj0013165
Score 2.3704395
Snippet What is already known about this subject • The occurrence of idiosyncratic drug hepatotoxicity is a major problem in all phases of clinical drug development...
The occurrence of idiosyncratic drug hepatotoxicity is a major problem in all phases of clinical drug development and the leading cause of postmarketing...
What is already known about this subject • The occurrence of idiosyncratic drug hepatotoxicity is a major problem in all phases of clinical drug development...
SourceID swepub
pubmedcentral
proquest
pubmed
crossref
wiley
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 253
SubjectTerms Adolescent
Adult
Alanine Transaminase - blood
Aspartate Aminotransferases - blood
Basic Medicine
Clinical Enzyme Tests - trends
clinical trials
Exercise - physiology
Farmakologi och toxikologi
gamma-Glutamyltransferase - blood
Humans
Liver - metabolism
Liver - pathology
liver function tests
Liver Function Tests - trends
Läkemedelskemi
Male
Medical and Health Sciences
Medicin och hälsovetenskap
Medicinal Chemistry
Medicinska och farmaceutiska grundvetenskaper
Methods in Clinical Pharmacology
Middle Aged
Muscle, Skeletal - metabolism
Pharmacology and Toxicology
physical exercise
Time Factors
Weight Lifting - physiology
Title Muscular exercise can cause highly pathological liver function tests in healthy men
URI https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fj.1365-2125.2007.03001.x
https://www.ncbi.nlm.nih.gov/pubmed/17764474
https://www.proquest.com/docview/70274544
https://pubmed.ncbi.nlm.nih.gov/PMC2291230
https://lup.lub.lu.se/record/608027
oai:portal.research.lu.se:publications/cd35c777-2589-48d4-999e-b2c9bcabbf04
Volume 65
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3dT9swELcmnnjZ90c3Bn6YeKJV6ji-5HEgENvEVG0gob1YtuMIRAnV0kh0fz13cdKSwUM17cFSJNdWc747_845_46xTxDlkRUYneDWmA2lQlO0zkRDR_WOxuQ0PR0NnHxXx2fy63ly3uY_0V2YwA-xPHAjy2j8NRm4sVXfyJsMLdyhWybCGF3uiPAkdRA--iFWHxTGTVVJQsgYeyXjflLPoxP1d6oH8PNhFmXLNdqHuc0-dfSMXXVvGNJTrkb13I7cn7_IH_-PCJ6zpy2c5Z-D_r1gT3z5ku1OAh_2Yo-frq53VXt8l09WTNmLV-znSR3yYHlX-YnjSmOr8YmIlKcLTiWTOwfNp5RFwmkvJn3iCJPnFb8sebjNueDXvnzNzo4OTw-Oh22Vh6FTGWAA60xqbYELZAup8sxhUORTGzlIMpEbJTxClsK4RCqRRzG6mELJHAorbQomsfEbtlHelP4d44nw0sfgjfIphp15lntnwVoRGQnSFAMG3Ypq11KgUyWOqb4XCqFENUmUCnSCbiSqbwdsvBw5CzQga4zZ6ZRGo83ShxhT-pu60kBnAYmUA_Y2qNBqTgAEqIA90FOu5Q-IDbzfU15eNKzgQmSIQqIBOwxq2BsyrWfYLDZdee3yOHEAoEWSZhoFJTXGCV5b4TK0VFyNCP_Br0fmCTGhbomoLtr5ZvdOmNecXDV6vbYs9f7BhJ7e_-vAD2wzZPpQItIW25j_rv1HhJNzu42O4su37cZd3AETxGpV
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Jb9QwFLZKOcCFfRm2-gA9dUaJ49jJgQN00XSZagRTqeJiYsdRK4Z0xExEw1_jr_BjeC9OZpq2hxFSDxwsRUpsJX77y_P3CHkrvdTTDKITMI1xlwsQRW0Sr2uw35GPStNiamBwKPpHfO84PF4hv5uzMA4fYp5wQ8mo9DUKOCak21JelWiBia6hCAPQub3zusJy35Y_IX6bvt_dAmK_Y2xne7TZ79YtBrpGxBKiJ5NEWmeBL3TGRRob8MhtpD0jw5iliWAW7GWWmJALlnoB8HcmeCozzXUkk1AHsO4tchsbiiNw_9YntviF4Vd9LNEnh2gv9NtlRNe-eds2XnF4r9Zt1uimbce6sow798mfZk9dQcy3XjHTPfPrEtzkf7rpD8i92mOnH5yIPSQrNn9E1ocO8rvcoKPFCbbpBl2nwwUYePmYfB4UrtSXNs2tKDAzjAKuECt6XFLsCt3YIDrGQhmK7gaKDIVIYDalpzl1B1ZL-t3mT8jRjXzwU7Kan-X2OaEhs9wG0ibCRhBZp3FqjZZaMy_hkidZh8iGhZSpUd6x2chYXYj2gIIKKYg9SKWqKKjOO8Sfz5w4pJMl5qw1XKpALeG_piS3Z8VUSUx3hJx3yDPHs4s1pQQfXMId2eLm-QMIeN6-k5-eVMDnjMXgaHkdsu34vjVlXExgaBhqapVJg9BIKRULo1jBRnEFoZBVmpkYlBFQw4M3-HLNOi7sVTXW1km93uRCEn3JxUUlSEvvpfq4OcSrF_86cY3c6Y8GB-pg93D_JbnrCpuw7uoVWZ39KOxr8J5n-k2lpSj5etMS-hfFIMe_
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9QwEB6VIiEuvB_Lqz5AT91V4jh2cuAA3a5aSqsVtFLFxY0dR61Y0hXZiIafxl_hzzCOk92G9rBC6oGDpUiJR4nn7Yy_AXgtvNRTFLMTdI1xn3FURaUTr69tvyPfGk1jtwb29vn2IftwFB6twK_2LIzDh5hvuFnNqO21VfBpmnWVvK7QQg_dIBEGaHIH502B5a6pfmD6VrzdGSKv31A62jrY3O43HQb6mscCkyedREplgc9VxngaawzITaQ8LcKYpgmnBt1lluiQcZp6AYp3xlkqMsVUJJJQBUj3Btxk3Itt24jhJ7r4g-HXbSxtSI7JXuh3q4iufPOua7wU714u22zATbtxde0YR3fhd7ukrh7m66CcqYH--Rfa5P-55vfgThOvk3dOwe7DiskfwPrYAX5XG-RgcX6t2CDrZLyAAq8ewue90hX6kra1FUFRxlHilUWKnlTE9oRuPRCZ2DIZYoMNqzAE84BZQU5z4o6rVuSbyR_B4bV88GNYzc9y8xRISA0zgTAJNxHm1WmcGq2EUtRLmGBJ1gPRSpDUDca7bTUykRdyPeSgtBy0HUiFrDkoz3vgz2dOHc7JEnPWWiGVaJTsn6YkN2dlIYXd7AgZ68ETJ7ILmkJgBC7wjugI8_wBC3fevZOfntSw55TGGGZ5PdhyYt-ZMimnOBQOWRip0yDUQghJwyiWuFBMYiJkpKI6RlOE3PDwDb5cQcclvbJB2jpp6E0vbKEvSZzXerT0Wsr3m2N79exfJ67BrfFwJD_u7O8-h9uuqskWXb2A1dn30rzE0HmmXtU2isDxdSvoH5jPxm4
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Muscular+exercise+can+cause+highly+pathological+liver+function+tests+in+healthy+men&rft.jtitle=British+journal+of+clinical+pharmacology&rft.au=Pettersson%2C+Jonas&rft.au=Hindorf%2C+Ulf&rft.au=Persson%2C+Paula&rft.au=Bengtsson%2C+Thomas&rft.date=2008-02-01&rft.issn=0306-5251&rft.eissn=1365-2125&rft.volume=65&rft.issue=2&rft.spage=253&rft.epage=259&rft_id=info:doi/10.1111%2Fj.1365-2125.2007.03001.x&rft.externalDBID=n%2Fa&rft.externalDocID=10_1111_j_1365_2125_2007_03001_x
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0306-5251&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0306-5251&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0306-5251&client=summon